《Pharmacopsychiatry》雜志的最新年發文量為25篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在藥學領域的學術影響力。
該刊聚焦于醫學-藥學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Pharmacopsychiatry 雜志發文統計
文章名稱引用次數
- Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?12
- Efficacy and Effectiveness of Lithium in the Long-Term Treatment of Bipolar Disorders: An Update 20188
- Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?6
- Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer's Disease5
- Lithium and Renal Impairment: A Review on a Still Hot Topic5
- Augmentation of Pharmacotherapy by Sleep Deprivation with Sleep Phase Advance in Treatment-Resistant Depression5
- Drink and Think: Impact of Alcohol on Cognitive Functions and Dementia - Evidence of Dose-Related Effects5
- Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials4
- Comparative Efficacy and Safety of Antipsychotic Drugs for Tic Disorders: A Systematic Review and Bayesian Network Meta-Analysis4
- Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials4
國家/地區發文量
- GERMANY (FED REP GER)132
- USA18
- Canada15
- Japan10
- Switzerland9
- Australia6
- CHINA MAINLAND6
- Poland6
- England5
- Italy5
